Close Menu

Gene Silencing/Gene Editing

News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.

The deal is part of a wider collaboration between the companies to develop molecular diagnostic tests using their respective platforms.

The company is in talks with potential partners in the US and China to validate the assay on clinical samples and deploy it at a large scale.

The grant was awarded through the Alzheimer's Drug Discovery Foundation's Diagnostic Accelerator, a partnership between the charity and philanthropic partners.

Two new grants are helping the company develop its SHERLOCK and INSPECTR technologies as the basis for creating innovative diagnostics.

The company said its test is faster, more precise, and cheaper than the current gold standard Cepheid GeneXpert test.